Zofran Latest Lawsuit News
24 February 2015

Woman Files Zofran Lawsuit In Minnesota For Heart Defects In Two Children

On February 12, 2015, a mother from Minnesota filed a lawsuit against drug giant GlaxoSmithKline (GSK), alleging that two of her children suffered congenital heart defects because plaintiff took Zofran for severe morning sickness during the first trimester of both pregnancies. This, the latest Zofran lawsuit was filed in federal court for the Eastern District of Pennsylvania under case number: 2:15-cv-00709PD.

The complaint alleges many of the same points as the first lawsuit filed against GSK alleged. However, in this lawsuit, plaintiff had two children who were born with birth defects, B.F. and T.F.

View Complaint: 2:15-cv-00709PD

Heart Defects Suffered By B.F. Because Of Zofran

Claimant’s first child, B.F. was born prematurely in 2004 and was diagnosed with a congenital heart defect. B.F. suffered developmental delays due to the birth defect and was placed in the fifth percentile with respect to growth metrics, when compared with other children of her age. B.F. had to have her cardiac septal defect, also known as hole in the heart, repaired by way of a surgical procedure in 2011.

Zofran Related Congenital Heart Defect Suffered By T.F.

Plaintiff’s second child, T.F. was born prematurely in 2006 with a heart defect. The complaint identified that T.F. required twenty four hour monitoring with specific monitors to assess her oxygen levels as her congenital heart defect caused her severe breathing difficulties. The defect greatly effected T.F.’s development in early years and she measured below the fifth percentile for growth.

Link Between Zofran Ingestion And Congenital Heart Defects

In both pregnancies, claimant was prescribed Zofran / Ondansetron during the first trimester of each pregnancy because she suffered from severe morning sickness. She never received a warning about the risks of Zofran from her doctors or from GSK. Plaintiff also had no family history of congenital heart defect and tested negative for a genetic anomaly. Had the Plaintiff known that Zofran would increase the risk of a child birth defect, and had she known about the studies connecting Zofran to congenital heart defects, she would not have taken Zofran.

How Much Is A Zofran Lawsuit Worth?

While this complaint is one of the first few lawsuits to be filed in this litigation, Plaintiffs appear to be identifying several damages against GSK, such as:

  • pain and suffering
  • economic and non-economic loss
  • emotional distress and anguish
  • medical expenses and future medical expenses
  • loss of consortium
  • punitive damages

Each case is unique and each child birth defect will have different facts and circumstances. Therefore there are no guidelines as to give as to the value of a lawsuit. If you would like a free case evaluation, please contact our Zofran lawyers today and we will evaluate whether you have a lawsuit against GSK.

We will post further complaints on this blog and will continue to monitor cases as they are filed.